Gustavo A. Cardenas, MD

Gustavo A. Cardenas, MD
Department of Internal Medicine, Cleveland Clinic Florida

Aldo Gonzalez-Serva, MD
Ameripath New England, Boston, Mass

Carlos Cohen, MD
Department of Dermatology, Cleveland Clinic Florida

Address: Carlos Cohen, MD, Cleveland Clinic Florida/Weston, 2900 Cleveland Clinic Boulevard, Weston, FL 33331

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gustavo A. Cardenas, MD
Department of Internal Medicine, Cleveland Clinic Florida

Aldo Gonzalez-Serva, MD
Ameripath New England, Boston, Mass

Carlos Cohen, MD
Department of Dermatology, Cleveland Clinic Florida

Address: Carlos Cohen, MD, Cleveland Clinic Florida/Weston, 2900 Cleveland Clinic Boulevard, Weston, FL 33331

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gustavo A. Cardenas, MD
Department of Internal Medicine, Cleveland Clinic Florida

Aldo Gonzalez-Serva, MD
Ameripath New England, Boston, Mass

Carlos Cohen, MD
Department of Dermatology, Cleveland Clinic Florida

Address: Carlos Cohen, MD, Cleveland Clinic Florida/Weston, 2900 Cleveland Clinic Boulevard, Weston, FL 33331

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gustavo A. Cardenas, MD
Department of Internal Medicine, Cleveland Clinic Florida

Ernesto G. Zavaleta, MD
Department of Internal Medicine, Cleveland Clinic Florida

Margaret J. Gorensek, MD
Chairman, Department of Infectious Disease, Cleveland Clinic Florida

Address: Margaret J. Gorensek, MD, Department of Infectious Disease, Cleveland Clinic Florida, 3000 West Cypress Creek Rd, Fort Lauderdale, FL 33309

Gustavo A. Cardenas, MD
Department of Internal Medicine, Cleveland Clinic Florida

Ernesto G. Zavaleta, MD
Department of Internal Medicine, Cleveland Clinic Florida

Margaret J. Gorensek, MD
Chairman, Department of Infectious Disease, Cleveland Clinic Florida

Address: Margaret J. Gorensek, MD, Department of Infectious Disease, Cleveland Clinic Florida, 3000 West Cypress Creek Rd, Fort Lauderdale, FL 33309

Gustavo A. Cardenas, MD
Department of Internal Medicine, Cleveland Clinic Florida

Ernesto G. Zavaleta, MD
Department of Internal Medicine, Cleveland Clinic Florida

Margaret J. Gorensek, MD
Chairman, Department of Infectious Disease, Cleveland Clinic Florida

Address: Margaret J. Gorensek, MD, Department of Infectious Disease, Cleveland Clinic Florida, 3000 West Cypress Creek Rd, Fort Lauderdale, FL 33309